本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

XBiotech Inc.

2.86
+0.02500.88%
成交量:1,595.00
成交額:4,527.64
市值:8,704.25萬
市盈率:-2.21
高:2.87
開:2.81
低:2.81
收:2.83
資料載入中...
2025/06/24

重要事件披露

Form 8-K - Current report
2025/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/30

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/01

重要事件披露

Form 8-K - Current report
2025/03/18

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/12/31

重要事件披露

Form 8-K - Current report
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/20

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/01

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/24

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

重要事件披露

Form 8-K - Current report
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]